Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 49 | 45 | −4 |
| Shares | 9.17M | 8.95M | −216.8K (−2.4%) |
| Value | $114.6M | $82.0M | −$32.6M (−28.5%) |
New holders (5)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| PDT Partners, LLC | 10,800 | $99.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 5,703 | $52.0K | 0.00% |
| CoreCap Advisors, LLC | 200 | $2.00K | 0.00% |
| Massmutual Trust Co FSB | 65 | $1.00K | 0.00% |
| Carmichael Hill & Associates, Inc. | 21 | $0 | 0.00% |
Sold out (9)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| OrbiMed Advisors LLC | 1,479,733 | $18.5M |
| Susquehanna International Group, LLP | 56,278 | $703.0K |
| Capital Investment Advisory Services, LLC | 15,125 | $189.0K |
| Parametric Portfolio Associates LLC | 12,465 | $156.0K |
| HighVista Strategies LLC | 10,944 | $137.0K |
| Advisor Group Holdings, Inc. | 1,200 | $15.0K |
| Simplex Trading, LLC | 897 | $11.0K |
| Benjamin F. Edwards & Company, Inc. | 500 | $6.00K |
| Cutler Group LP | 300 | $3.00K |